Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Nana Weber‐Lassalle"'
Autor:
Nana Weber-Lassalle, Julika Borde, Konstantin Weber-Lassalle, Judit Horváth, Dieter Niederacher, Norbert Arnold, Silke Kaulfuß, Corinna Ernst, Victoria G. Paul, Ellen Honisch, Kristina Klaschik, Alexander E. Volk, Christian Kubisch, Steffen Rapp, Nadine Lichey, Janine Altmüller, Louisa Lepkes, Esther Pohl-Rescigno, Holger Thiele, Peter Nürnberg, Mirjam Larsen, Lisa Richters, Kerstin Rhiem, Barbara Wappenschmidt, Christoph Engel, Alfons Meindl, Rita K. Schmutzler, Eric Hahnen, Jan Hauke
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-6 (2019)
Abstract Background The role of the BARD1 gene in breast cancer (BC) and ovarian cancer (OC) predisposition remains elusive, as published case-control investigations have revealed controversial results. We aimed to assess the role of deleterious BARD
Externí odkaz:
https://doaj.org/article/6542c7dcf6614ef1973c45fb57592c84
Autor:
Jan Hauke, Judit Horvath, Eva Groß, Andrea Gehrig, Ellen Honisch, Karl Hackmann, Gunnar Schmidt, Norbert Arnold, Ulrike Faust, Christian Sutter, Julia Hentschel, Shan Wang‐Gohrke, Mateja Smogavec, Bernhard H. F. Weber, Nana Weber‐Lassalle, Konstantin Weber‐Lassalle, Julika Borde, Corinna Ernst, Janine Altmüller, Alexander E. Volk, Holger Thiele, Verena Hübbel, Peter Nürnberg, Katharina Keupp, Beatrix Versmold, Esther Pohl, Christian Kubisch, Sabine Grill, Victoria Paul, Natalie Herold, Nadine Lichey, Kerstin Rhiem, Nina Ditsch, Christian Ruckert, Barbara Wappenschmidt, Bernd Auber, Andreas Rump, Dieter Niederacher, Thomas Haaf, Juliane Ramser, Bernd Dworniczak, Christoph Engel, Alfons Meindl, Rita K. Schmutzler, Eric Hahnen
Publikováno v:
Cancer Medicine, Vol 7, Iss 4, Pp 1349-1358 (2018)
Abstract The prevalence of germ line mutations in non‐BRCA1/2 genes associated with hereditary breast cancer (BC) is low, and the role of some of these genes in BC predisposition and pathogenesis is conflicting. In this study, 5589 consecutive BC i
Externí odkaz:
https://doaj.org/article/ef20fad57668492e8e5c076a0c75dc32
Autor:
Nana Weber-Lassalle, Jan Hauke, Juliane Ramser, Lisa Richters, Eva Groß, Britta Blümcke, Andrea Gehrig, Anne-Karin Kahlert, Clemens R. Müller, Karl Hackmann, Ellen Honisch, Konstantin Weber-Lassalle, Dieter Niederacher, Julika Borde, Holger Thiele, Corinna Ernst, Janine Altmüller, Guido Neidhardt, Peter Nürnberg, Kristina Klaschik, Christopher Schroeder, Konrad Platzer, Alexander E. Volk, Shan Wang-Gohrke, Walter Just, Bernd Auber, Christian Kubisch, Gunnar Schmidt, Judit Horvath, Barbara Wappenschmidt, Christoph Engel, Norbert Arnold, Bernd Dworniczak, Kerstin Rhiem, Alfons Meindl, Rita K. Schmutzler, Eric Hahnen
Publikováno v:
Breast Cancer Research, Vol 20, Iss 1, Pp 1-6 (2018)
Abstract Background Germline mutations in the BRIP1 gene have been described as conferring a moderate risk for ovarian cancer (OC), while the role of BRIP1 in breast cancer (BC) pathogenesis remains controversial. Methods To assess the role of delete
Externí odkaz:
https://doaj.org/article/951e74b0cfc6446ab5113f955636b95b
Autor:
Konstantin Weber-Lassalle, Corinna Ernst, Alexander Reuss, Kathrin Möllenhoff, Klaus Baumann, Christian Jackisch, Jan Hauke, Dimo Dietrich, Julika Borde, Tjoung-Won Park-Simon, Lars Hanker, Katharina Prieske, Sandra Schmidt, Nana Weber-Lassalle, Esther Pohl-Rescigno, Stefan Kommoss, Frederik Marmé, Florian Heitz, Julia C Stingl, Rita K Schmutzler, Philipp Harter, Eric Hahnen
Publikováno v:
JNCI: Journal of the National Cancer Institute. 114:565-570
Background Cancer patients are at risk of secondary therapy–related myeloid neoplasms (t-MNs). Acquired blood-specific mutations in clonal hematopoiesis (CH)–associated genes are t-MN risk factors, and their occurrence associated with cancer ther
Autor:
H Haverkamp, U. Nitz, R Kates, Matthias Christgen, Lisa Richters, E-M. Grischke, S. Kuemmel, Rachel Wuerstlein, O Gluz, H.H. Kreipe, Nana Weber-Lassalle, Monika Graeser, Corinna Ernst, M Kayali, Michael Braun, R Schmutzler, Jan Hauke, Nadia Harbeck, Eric Hahnen, M. Warm
Publikováno v:
Senologie - Zeitschrift für Mammadiagnostik und -therapie.
Autor:
Kristina Lübbe, Valentina Nekljudova, Esther Pohl-Rescigno, Christian Jackisch, Nana Weber-Lassalle, Kerstin Rhiem, Michael Untch, Holger Thiele, Jenny Furlanetto, Volker Möbus, Corinna Ernst, Bianca Lederer, Claus Hanusch, Peter A. Fasching, Andreas Schneeweiss, Jan Hauke, Mohamad Kayali, Volkmar Müller, Peter Nürnberg, Sibylle Loibl, Hans Tesch, Rita K. Schmutzler, Eric Hahnen, Janine Altmüller, Carsten Denkert
Publikováno v:
JAMA Oncol
IMPORTANCE: The GeparOcto randomized clinical trial compared the efficacy of 2 neoadjuvant breast cancer (BC) treatment regimens: sequential intense dose-dense epirubicin, paclitaxel, and cyclophosphamide (iddEPC) vs weekly paclitaxel and nonpegylate
Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis
Autor:
Jan Hauke, Christoph Engel, Esther Pohl-Rescigno, Stefan Kommoss, Philipp Harter, Julia C. Stingl, Julika Borde, Frederik Marmé, Dimo Dietrich, Nana Weber-Lassalle, Eric Hahnen, Katharina Prieske, Rita K. Schmutzler, Corinna Ernst, Beyhan Ataseven, Konstantin Weber-Lassalle, Alexander Reuss
Publikováno v:
Human Mutation. 39:2040-2046
The Li-Fraumeni cancer predisposition syndrome (LFS1) presents with a variety of tumor types and the TP53 gene is covered by most diagnostic cancer gene panels. We demonstrate that deleterious TP53 variants identified in blood-derived DNA of 523 pati
Autor:
Christoph Engel, Ellen Honisch, Walter Just, Eva Groß, Nana Weber-Lassalle, Dieter Niederacher, Juliane Ramser, Lisa Richters, Kristina Klaschik, Konrad Platzer, Peter Nürnberg, Guido Neidhardt, Clemens R. Müller, Norbert Arnold, Britta Blümcke, Christopher Schroeder, Corinna Ernst, Barbara Wappenschmidt, Andrea Gehrig, Gunnar Schmidt, Julika Borde, Bernd Auber, Holger Thiele, Janine Altmüller, Alfons Meindl, Konstantin Weber-Lassalle, Karl Hackmann, Bernd Dworniczak, Christian Kubisch, Anne-Karin Kahlert, Eric Hahnen, Kerstin Rhiem, Judit Horvath, Jan Hauke, Shan Wang-Gohrke, Alexander E Volk, Rita K. Schmutzler
Publikováno v:
Breast Cancer Research, Vol 20, Iss 1, Pp 1-6 (2018)
Breast Cancer Research : BCR
Breast Cancer Research : BCR
Background Germline mutations in the BRIP1 gene have been described as conferring a moderate risk for ovarian cancer (OC), while the role of BRIP1 in breast cancer (BC) pathogenesis remains controversial. Methods To assess the role of deleterious BRI
Autor:
Jan Hauke, Lisa Richters, Matthias Christgen, Michael Braun, Oleg Gluz, Monika Graeser, Ronald E. Kates, Mathias Warm, Nadia Harbeck, Rachel Wuerstlein, Corinna Ernst, Mohamad Kayali, Nana Weber-Lassalle, S. Kuemmel, Rita K. Schmutzler, Hans Kreipe, Ulrike Nitz, Eric Hahnen, Eva-Maria Grischke, Heinz Haverkamp
Publikováno v:
Journal of Clinical Oncology. 39:579-579
579 Background: The phase II trial WSG-ADAPT TN randomized triple-negative breast cancer (TNBC) patients to receive 12 weeks of neoadjuvant nab-paclitaxel (nab-pac) combined with carboplatin (carbo) vs gemcitabine (gem) and showed a substantial impro
Autor:
Esther Pohl-Rescigno, Julika Borde, Guido Neidhardt, Elisabeth Mangold, Christian Tränkle, Alfons Meindl, Harald Surowy, Norbert Arnold, Jan Hauke, Christian Sutter, Nana Weber-Lassalle, Kristina Klaschik, Gunter Rappl, Christoph Engel, Stefanie Heilmann-Heimbach, Dieter Niederacher, Sandra Schmidt, Eric Hahnen, Rita K. Schmutzler, Barbara Burwinkel, Barbara Wappenschmidt, Corinna Ernst, Konstantin Weber-Lassalle
Publikováno v:
International journal of cancer. 144(7)